MATH+ Protocol Includes Ivermectin Option for Prophylaxis and Early Treatment of COVID-19; Phase of Disease Key to Care (US 2020-10-14) TrialSiteNews Dr. Marik (Eastern Kentucky Medical School) protocol recommends (optionally) IVM for prophylaxis (!), outpatients and mildly-ill inpatients

[-] TrumpLyftAlles | 1 points | Oct 15 2020 06:04:02

Someone posted this as a comment on the article:

Dr. Marik’s protocol has included ivermectin 150-200mg as optional treatment of infected patients at home or mildly-ill hospitalized patients, going all the way back to May 28 (my oldest version of his protocol).

The difference between the most recent version (2020-09-28) and the next-most-recent version I have (2020-08-01) is the ADDITION of ivermectin for PROPHYLAXIS — for uninfected people trying to avoid catching COVID-19.

Optonal: Ivermectn for postexposure prophylaxis (see ClinTrials.gov NCT04422561)

That trial is the Egyptian study that gave newly-covid+ patients enough ivermectin so the new patient’s household members could take two doses. Only 7.4% of household members who took ivermectin caught the virus, compared to 58.4% of those in the without-ivermectin households, during the ensuing 3 weeks. I wrote it up here:

https://www.reddit.com/r/ivermectin/comments/ihvbjc/prophylactic_ivermectin_in_covid19_contacts_egypt/

Between 2020-08-01 and 2020-09-28, Dr. Marik also added to his recommended prophylaxis regimen:

• Famotidine 20-40 mg/day

• Optonal/Experimental: Interferon-α nasal spray for health care workers

This is the paper Dr. Marik cites as the basis for the nasal spray recommendation:

https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2

I posted the link in case someone wants to read it, and googles the title, which oddly doesn’t work; google returns a couple unrelated papers. I found it using bing. I’m not shilling for bing, honest!

💖 Ivermectin for prophylaxis! 😍

Who needs a 50-70% effective vaccine? 🤷‍♀️🤷‍♂️

(Not that I’ll turn down the vaccine, when it finally arrives.)

[-] Ok-Film-9049 | 2 points | Oct 18 2020 17:02:43

I watched Paul mariks his latest video on YouTube. Asked him about CD147 thorey for IVM. He just said it was anti inflammatory and anti viral. Didn't elaborate on the anti coagulant stuff. No many people watch his videos so you have a reasoble chance to ask questions

[-] TrumpLyftAlles | 1 points | Oct 18 2020 18:41:57

It's cool that he has twigged onto ivermectin being anti-inflammatory!

Would you please give me a link to the video?

I emailed him 3 days ago, asking him to reply with a paragraph about his experience with ivermectin, and gave him a link to the Argentina prophylaxis study (788 health workers uninfected after 10 weeks with ivermectin + carrageenan). He thanked me for the link but otherwise didn't respond, esp. didn't write anything about ivermectin.

Maybe I'll tune in for his next video. Do they appear on a schedule?

[-] Ok-Film-9049 | 1 points | Oct 18 2020 20:01:16

https://youtu.be/GhL2FPcBHHQ Here it is. Yes I think my answer may have been a bit of a stock answer but we can but try! It was called Covid 19 : a clinical update Posted a day ago I subscribed to his chanell but don't seem to get a reminder Maybe I am just a bit useless with Youtube

[-] TrumpLyftAlles | 2 points | Oct 18 2020 20:25:19

Maybe I am just a bit useless with Youtube

I've subscribed to dozens of channels and never get reminders?!

Thanks for the link!

[-] LinkifyBot | 1 points | Oct 15 2020 06:04:27

I found links in your comment that were not hyperlinked:

ClinTrials.gov

I did the honors for you.

^delete ^| ^information ^| ^<3

[-] movethroughit | 1 points | Oct 17 2020 04:04:44

Psst - Eastern Virginia Medical School.

I started following Marik back before Covid because influenza can also go bad and turn into pneumonia, sepsis and a Cytokine Storm. Marik was always at the forefront with early treatment and megadose IV Vitamin C. Checking out the RCTs that tried to replicate his method is a good lesson in seeing ignorance in action, mainly by waiting far too long to begin therapy, using too little Vitamin C, stopping too soon, plus choosing the wrong endpoints. Still, CITRIS-ALI had some positive findings:

https://emcrit.org/pulmcrit/pulmcrit-citris-ali-can-a-secondary-endpoint-stage-a-coup-detat/

Note in the graph (Figure 3) where treatment began, ended and the diversion from mortality in the placebo arm. It's difficult to see the shaded area that represents the treatment period, but it's there. After the treatment period ended, the Vit C arm starts to get closer to the placebo arm.